COYA THERAPEUTICS INC (COYA) Stock Income Statement
NASDAQ:COYA - Nasdaq - US22407B1089 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.69M | 3.55M | 6.00M | 0.00 | 0.00 | |||
| Operating Expenses | 23.13M | 20.78M | 13.36M | 9.81M | 4.87M | |||
| Research and Development | 13.94M | 11.87M | 5.50M | 4.94M | 2.54M | |||
| Selling, General, and Administrative Expenses | 9.16M | 8.89M | 7.83M | 4.85M | 2.31M | |||
| Operating Income | -19.44M | -17.22M | -7.36M | -9.81M | -4.87M | |||
| Interest Income/Expense | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Income/Expense | 1.59M | 1.65M | 639.40K | -2.43M | -20.00K | |||
| Non Recurring Items | 0.00 | -25.00K | -543.20K | N/A | N/A | |||
| Income Before Taxes | -17.86M | -15.60M | -7.26M | -12.24M | -4.89M | |||
| Income Tax | N/A | -720.30K | 723.90K | N/A | N/A | |||
| Net Income | -17.14M | -14.88M | -7.99M | -12.24M | -4.89M | |||
| EBITDA | -19.42M | -17.20M | -7.33M | -9.78M | -4.85M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.07 | -0.98 | -0.79 | -1.23 | -0.51 | |||
| Non GAAP EPS | -1.06 | -0.97 | -0.79 | N/A | N/A | |||
| Statistics | ||||||||
| Profit Margin | -464.99% | -418.69% | -133.08% | N/A | N/A | |||
| Operating Profit Margin | -527.61% | -484.64% | -122.63% | N/A | N/A | |||
All data in USD